Improvements in liver inflammation and fibrosis induced by the activation of liver Nrf2 may be implicated in the effect of the exercise to ameliorate liver defects in patients with NAFLD. Here, NFE2L2 is linked to metabolic dysfunction-associated steatotic liver disease.